The WACC of Royalty Pharma PLC (RPRX) is 6.3%.
| Range | Selected | |
| Cost of equity | 5.70% - 8.70% | 7.20% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 4.9% - 7.7% | 6.3% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.4 | 0.68 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.70% | 8.70% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.4 | 0.4 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 4.9% | 7.7% |
| Selected WACC | 6.3% | |